GenScript Biotech leaders named finalists for Entrepreneur of the Year award

On April 23, 2026, GenScript Biotech Corporation achieved a significant milestone as its CEO, Sherry Shao, and Co-Founder, Dr.

Frank Zhang, were named finalists for the prestigious Entrepreneur Of The Year® 2026 New Jersey Award.

Organized by Ernst & Young LLP (EY), this honor recognizes leaders who demonstrate exceptional innovation, growth, and long-term societal impact.

Founded in New Jersey in 2002, GenScript has evolved from a pioneering gene synthesis firm into a global biotechnology powerhouse.

Today, the company serves researchers and pharmaceutical innovators across more than 100 countries, driven by a mission to make biotechnology accessible and efficient.

Zhang is celebrated for establishing the company's foundational vision, while Sherry Shao, appointed as rotating CEO in 2023, is recognized for steering the organization through a period of substantial global growth and transformation.

The regional winners for New Jersey will be revealed on June 4, 2026, with the successful candidates moving on to the national competition in November.